- Home
- NVCR vs CRTO Comparison
NVCR vs CRTO Comparison
Compare NVCR & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVCR | CRTO |
|---|---|---|
| Founded | 2000 | 2005 |
| Country | Switzerland | France |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2015 | 2013 |
Fundamental Metrics
Financial Performance| Metric | NVCR | CRTO |
|---|---|---|
| Price | $13.70 | $20.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 9 |
| Target Price | $28.42 | ★ $38.67 |
| AVG Volume (30 Days) | ★ 1.7M | 481.2K |
| Earning Date | 10-30-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 83.79 |
| EPS | N/A | ★ 3.00 |
| Revenue | $642,269,000.00 | ★ $1,956,800,000.00 |
| Revenue This Year | $9.75 | N/A |
| Revenue Next Year | $5.62 | $1.42 |
| P/E Ratio | ★ N/A | $6.83 |
| Revenue Growth | ★ 11.17 | 0.53 |
| 52 Week Low | $10.70 | $19.00 |
| 52 Week High | $34.13 | $47.27 |
Technical Indicators
Market Signals| Indicator | NVCR | CRTO |
|---|---|---|
| Relative Strength Index (RSI) | 64.34 | 52.39 |
| Support Level | $10.79 | $20.25 |
| Resistance Level | $11.86 | $21.48 |
| Average True Range (ATR) | 0.64 | 0.76 |
| MACD | 0.23 | 0.15 |
| Stochastic Oscillator | 93.17 | 71.57 |
Price Performance
Historical ComparisonAbout NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About CRTO Criteo S.A.
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.